
    
      Double Blind Period: Treatment, Parallel Assignment, Double Blind (Subject, Investigator),
      Randomized, Active Control, Safety/Efficacy Study

      Open Label Period: Prevention, Single Group Assignment, Open Label, Uncontrolled,
      Safety/Efficacy Study
    
  